Home Newsfeeds Citigroup Maintains Neutral on Texas Instruments, Raises Price Target to $175

Citigroup Maintains Neutral on Texas Instruments, Raises Price Target to $175

Citigroup analyst Christopher Danely maintains Texas Instruments (NASDAQ:TXN) with a Neutral and raises the price target from $155 to $175.

byBenzinga Newsdesk

January 18, 2023

1 minute read

Citigroup analyst Christopher Danely maintains Texas Instruments (NASDAQ:TXN) with a Neutral and raises the price target from $155 to $175.

47% Of Small Business Owners Fear They’ll Be Closed For Good In The Fall: Report

By Phil Hall

July 15, 3:56 PM

The U.S. small business community has seen the near future — and nearly half of don’t see themselves continuing to operate in it.

SPY

Noble Q3 EPS $0.50 Beats $0.39 Estimate, Sales $305.87M Beat $291.52M Estimate

By Benzinga Newsdesk

November 3, 2:15 AM

Noble (NYSE:NE) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.39 by 28.21 percent. This is a 233.33 percent increase over earnings of $0.15 per share from the same period

Cue Health Becomes First Company to Receive FDA De Novo Authorization COVID-19 Home Use Test

By Vandana Singh

June 7, 8:54 AM

Cue Health Inc (NASDAQ: HLTH) became the first company to receive De Novo authorization from the FDA for its Cue COVID-19 Molecular Test, designed for both home and

HLTH